BKR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Baker Hughes is not a clear buy right now for a beginner long-term investor, despite decent analyst support and strong institutional buying. The stock is oversold technically, but momentum is weak and there is no proprietary buy signal today. Given the lack of a strong entry signal and the mixed near-term trend, the best call is to hold rather than buy aggressively at this moment.
BKR is trading at 52.91, slightly above the option reference price of 52.78 and just above S1 at 53.288 but still below the pivot of 56.241, showing it remains under short-term pressure. MACD histogram is -0.671 and negatively expanding, which confirms bearish momentum. RSI_6 at 11.161 indicates the stock is deeply oversold, so a rebound is possible, but oversold alone does not confirm a trend reversal. Moving averages are converging, suggesting the selloff may be stabilizing, but the current trend is still weak. The stock trend model also points to mild negative forward returns over the next day, week, and month.
Analyst sentiment remains generally constructive, with multiple firms keeping Buy/Outperform-style ratings and several raising price targets into the $71-$80 range. TD Cowen recently increased its target to $77 and reiterated Buy, citing solid performance in OFSE and IET and order momentum. Hedge funds are also accumulating the stock strongly, with buying up 293.05% last quarter. The company is also approaching its Q2 2026 earnings release, which could serve as a catalyst if results confirm the strong IET order trend.
Insiders are selling heavily, with selling up 343.07% over the last month, which is a negative sentiment signal. The stock has weak near-term technical momentum, with MACD still deteriorating and the recent trend model pointing to slight downside over the next several periods. The latest price is below the key pivot, showing the market has not yet reclaimed a stronger trend structure. No recent congress trading data or major political/influential buying support is available.
No latest-quarter financial statement data was available due to a financial snapshot error, so I cannot assess revenue or earnings growth directly. However, analyst commentary on the most recent quarter was positive: Q1 results were described as strong in Industrial & Energy Technology, with record IET orders of $4.9 billion, improving margins, and solid demand across power, LNG, and gas infrastructure. That suggests healthy operating momentum in the latest reported quarter season.
Wall Street is still mostly constructive on BKR, but the tone is slightly mixed. Recent updates include several Buy/Outperform/Positive ratings and higher targets, while some firms trimmed targets or stayed Neutral. TD Cowen raised its target to $77 and kept Buy; BofA, Citi, BMO, Susquehanna, and RBC all remain broadly positive with targets mostly in the low-to-mid $70s or $80 area. Barclays downgraded to Equal Weight even while raising its target to $74, reflecting a more balanced pros-and-cons view. Overall, pros include strong IET order growth, solid long-term energy/industrial positioning, and higher target prices; cons include some valuation caution, mixed rating dispersion, and near-term execution sensitivity.
